Joel Greenblatt's EMN Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 326,783 shares of Eastman Chemical Company (EMN) worth $20.86 M, representing 0.08% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 46 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in EMN, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2015, adding 182,989 shares. Largest reduction occurred in Q1 2015, reducing 202,750 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Eastman Chemical Company (EMN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eastman Chemical Company (EMN) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +125,206 | Add 62.11% | 326,783 | $63.83 |
| Q3 2025 | +107,218 | Add 113.63% | 201,577 | $63.05 |
| Q2 2025 | -1,279 | Reduce 1.34% | 94,359 | $74.66 |
| Q1 2025 | +7,875 | Add 8.97% | 95,638 | $88.11 |
| Q4 2024 | +60,177 | Add 218.14% | 87,763 | $91.32 |
| Q3 2024 | +15,091 | Add 120.78% | 27,586 | $111.95 |
| Q2 2024 | -24,803 | Reduce 66.50% | 12,495 | $97.97 |
| Q1 2024 | +2,447 | Add 7.02% | 37,298 | $100.22 |
| Q4 2023 | +28,864 | Add 482.11% | 34,851 | $89.82 |
| Q3 2023 | -27,564 | Reduce 82.16% | 5,987 | $76.72 |
| Q2 2023 | -23,456 | Reduce 41.15% | 33,551 | $83.72 |
| Q1 2023 | -14,479 | Reduce 20.25% | 57,007 | $84.34 |
| Q4 2022 | -33,394 | Reduce 31.84% | 71,486 | $81.44 |
| Q3 2022 | +78,454 | Add 296.88% | 104,880 | $71.05 |
| Q2 2022 | -22,873 | Reduce 46.40% | 26,426 | $89.76 |
| Q1 2022 | +23,285 | Add 89.51% | 49,299 | $112.05 |
| Q4 2021 | +5,838 | Add 28.94% | 26,014 | $120.90 |
| Q3 2021 | +2,337 | Add 13.10% | 20,176 | $100.76 |
| Q2 2021 | -8,792 | Reduce 33.01% | 17,839 | $116.77 |
| Q1 2021 | -13,451 | Reduce 33.56% | 26,631 | $110.13 |
| Q4 2020 | +2,374 | Add 6.30% | 40,082 | $100.27 |
| Q3 2020 | -32,132 | Reduce 46.01% | 37,708 | $78.13 |
| Q2 2020 | -48,716 | Reduce 41.09% | 69,840 | $69.64 |
| Q1 2020 | +11,599 | Add 10.84% | 118,556 | $46.58 |
| Q4 2019 | +49,974 | Add 87.70% | 106,957 | $79.26 |
| Q3 2019 | -124,123 | Reduce 68.54% | 56,983 | $73.83 |
| Q2 2019 | -40,226 | Reduce 18.17% | 181,106 | $77.83 |
| Q1 2019 | +161,191 | Add 268.02% | 221,332 | $75.88 |
| Q4 2018 | +47,597 | Add 379.44% | 60,141 | $73.11 |
| Q3 2018 | -17,362 | Reduce 58.06% | 12,544 | $95.74 |
| Q2 2018 | -27,030 | Reduce 47.47% | 29,906 | $99.95 |
| Q1 2018 | +36,591 | Add 179.85% | 56,936 | $105.57 |
| Q4 2017 | +20,345 | New Buy | 20,345 | $92.65 |
| Q1 2017 | -43,848 | Sold Out | 0 | $0.00 |
| Q4 2016 | +33,103 | Add 308.08% | 43,848 | $75.21 |
| Q3 2016 | +6,443 | Add 149.77% | 10,745 | $67.66 |
| Q2 2016 | -93,797 | Reduce 95.61% | 4,302 | $67.88 |
| Q1 2016 | -47,022 | Reduce 32.40% | 98,099 | $72.23 |
| Q4 2015 | -37,868 | Reduce 20.69% | 145,121 | $67.51 |
| Q3 2015 | +182,989 | New Buy | 182,989 | $64.72 |
| Q1 2015 | -202,750 | Sold Out | 0 | $0.00 |
| Q4 2014 | +110,210 | Add 119.09% | 202,750 | $75.86 |
| Q3 2014 | +31,250 | Add 50.99% | 92,540 | $80.89 |
| Q2 2014 | -17,571 | Reduce 22.28% | 61,290 | $87.36 |
| Q1 2014 | +32,580 | Add 70.40% | 78,861 | $86.21 |
| Q4 2013 | +46,281 | New Buy | 46,281 | $80.70 |
Joel Greenblatt's Eastman Chemical Company Investment FAQs
Joel Greenblatt first purchased Eastman Chemical Company (EMN) in Q4 2013, acquiring 46,281 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Eastman Chemical Company (EMN) for 46 quarters since Q4 2013.
Joel Greenblatt's largest addition to Eastman Chemical Company (EMN) was in Q3 2015, adding 182,989 shares worth $11.84 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 326,783 shares of Eastman Chemical Company (EMN), valued at approximately $20.86 M.
As of the Q4 2025 filing, Eastman Chemical Company (EMN) represents approximately 0.08% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Eastman Chemical Company (EMN) was 326,783 shares, as reported at the end of Q4 2025.